ICD-10-CM Billable Code

M90.67

Osteitis deformans in neoplastic diseases, ankle and foot

Clinical Classification Guidelines

Medical Intelligence & Overview

Osteitis deformans, also known as Paget's disease of the bone, is a chronic disorder that involves the abnormal breakdown and formation of bone tissue. When this condition occurs in individuals with neoplastic diseases affecting the ankles and feet, it can lead to significant bone deformities and complications. The ICD-10 code M90.67 specifically refers to osteitis deformans localized in the ankle and foot regions in the context of neoplastic diseases. This condition requires careful management to prevent further bone damage and maintain mobility.

Causes & Symptoms

Clinical Causes: Genetic predisposition, particularly variations in genes involved in bone remodeling Environmental factors, such as viral infections that may trigger abnormal bone activity Underlying neoplastic diseases, which can disrupt normal bone turnover processes Age-related changes, as Paget's disease predominantly affects older adults

Key Symptoms: Bone pain, which may worsen at night or during activity Swelling and tenderness around the affected ankle and foot Deformities in the shape or size of the bones in the area Reduced mobility or stiffness in the ankle and foot joints Increased warmth over the affected bones Possible nerve compression symptoms, such as numbness or tingling, if nearby nerves are affected

Diagnostic & Treatment

Diagnosis Path: Diagnosis of osteitis deformans in the context of neoplastic diseases involves a combination of clinical evaluation and imaging studies. Healthcare providers may recommend the following tests: - X-rays to observe characteristic bone changes like thickening, deformities, or lesions related to Paget's disease - Bone scans or nuclear medicine tests to assess the extent of bone involvement - MRI or CT scans for detailed imaging, especially if complications or surrounding tissue involvement are suspected - Laboratory tests, including elevated levels of serum alkaline phosphatase, which are indicative of increased bone turnover - Biopsy in some cases to differentiate between reactive changes and neoplastic involvement

Treatment Protocols: Managing osteitis deformans, particularly in patients with concurrent neoplastic diseases, involves a multidisciplinary approach. Typical management strategies include: - Bisphosphonates to slow down abnormal bone remodeling, reduce pain, and prevent further deformities - Pain-relief medications such as NSAIDs - Physical therapy to maintain joint mobility and strength - Surgical interventions, such as corrective osteotomies or joint replacements, if deformities are severe or cause significant functional impairment - Treatment of the underlying neoplastic disease to address the primary pathology - Regular monitoring with imaging and laboratory tests to assess disease progression and treatment response

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M90.67 a billable ICD-10 code?
Yes, M90.67 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M90.67?
Clinical documentation must specify the nature of Osteitis deformans in neoplastic diseases, ankle and foot and any associated comorbidities for accurate reporting.

Cite this Clinical Reference